Featured Articles
-
The Smart, Savvy Science Driving Viral Vector Scale-Up
4/8/2024
Learn about cutting-edge strategies, including alternatives to plasmid-based transient transfection, aimed at addressing current process challenges and bringing revolutionary treatments to patients in need.
-
Top Challenges In Recombinant Protein Purification Process Development
3/27/2024
Get insights from process developers working with recombinant proteins that cannot be purified with affinity chromatography.
-
Building Biopharma Resilience In Developing Gene Therapies
3/21/2024
Learn about the opportunities and challenges surrounding gene therapies, the importance of collaboration between biopharma startups and academia, difficulties with the talent pipeline, and more.
-
Biopharmaceuticals: State Of The Industry
3/21/2024
How are government policies, talent pools, and supply chain constraints affecting the state of the industry? Learn about the biopharma industry’s biggest strengths, greatest challenges, and much more.
-
Biopharma Resilience: Mass Immunization Programs
3/21/2024
Explore the challenges involved with mass immunization programs, what role government can play in facilitating vaccination programs, how technology is transforming the biopharma industry, and more.
-
Manufacturing Challenges With High Concentration Biologics
3/18/2024
Explore key process operations, some of the challenges in manufacturing high-concentration biologics, and factors to consider for process optimization.
-
High-Concentration Drug Manufacturing Challenges And Opportunities
3/18/2024
The demand for high-concentration/subcutaneous drugs is on the rise. Explore opportunities for enhancing your biotech drug production platform.
-
Scaling Personalized Medicines For Flexible Aseptic Filling
2/14/2024
Traditional aseptic filling solutions can introduce contamination and variability. Learn about Cytiva's commitment to finding innovative solutions and improving patient outcomes in the field of medicine.
-
A New Reality In Life Sciences
2/14/2024
Gain insight from this author's experience with virtual reality (VR) and the specific benefits of VR in scientific contexts.
-
Big Risks Yield Great Rewards In Cell Therapy
2/14/2024
George White, Cytiva’s GM of Product Management for Cell and Gene Therapy, provides insight into the latest developments and strategies in cell therapy and where this dynamic field is headed.